LBA48 Clinical efficacy and immunity of combination therapy with nivolumab and IDO/PD-L1 peptide vaccine in patients with metastatic melanoma: A phase I/II trial
Inge Marie Svane, Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, Mads Hald Andersen
Topics & Concepts
MedicineNivolumabPeptide vaccineInternal medicineMelanomaMetastatic melanomaIpilimumabOncologyClinical trialImmunotherapyPhases of clinical researchImmune systemVaccinationProgression-free survivalImmunologyAntibodyCancerChemotherapyCancer researchEpitopeCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research